Prognostic Nutritional Index Predicts Outcome of PD-L1 Negative and MSS Advanced Cancer Treated with PD-1 Inhibitors

PURPOSE: Tumor mutational burden (TMB), microsatellite instability-high (MSI-H), and expression of programmed death ligand-1 (PD-L1) have emerged as predictive biomarkers for responsiveness to immune checkpoint inhibitors (ICIs) in several cancer types. However, for patients with negative PD-L1 expr...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yan, Jin, Jun, Tang, Min, Li, Ping, Zhou, Li-Na, Du, Yi-Ping, Chen, Min-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192216/
https://www.ncbi.nlm.nih.gov/pubmed/35707390
http://dx.doi.org/10.1155/2022/6743126

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192216/
https://www.ncbi.nlm.nih.gov/pubmed/35707390
http://dx.doi.org/10.1155/2022/6743126

Ejemplares similares